Clinical Trials Logo

Apnea clinical trials

View clinical trials related to Apnea.

Filter by:

NCT ID: NCT00984308 Completed - Stroke Clinical Trials

Diagnosis and Treatment of Sleep Apnea in Cerebrovascular Disease

Go To Sleep
Start date: December 2008
Phase: Phase 2/Phase 3
Study type: Interventional

Sleep apnea is common among Veterans with cerebrovascular disease (stroke or transient ischemic attack [TIA]), leads to hypertension, and is associated with recurrent stroke and death. Although continuous positive airway pressure (CPAP) safely treats sleep apnea, few Veterans with cerebrovascular disease are diagnosed with sleep apnea or offered treatment.

NCT ID: NCT00965783 Completed - Obesity Clinical Trials

Predictors of the Metabolic Effect of Sleep Loss

SDBO
Start date: June 2007
Phase: N/A
Study type: Interventional

To test whether baseline levels of slow wave activity (SWA) during sleep are lower in obese adults, and even lower in persons with sleep disordered breathing (SDB) compared to lean adults. To compare levels of SWA in individuals in relation to their sleep time, blood pressure, heart rate, and markers of glucose metabolism.

NCT ID: NCT00957463 Completed - Clinical trials for Obstructive Sleep Apnea

Effects of Obstructive Sleep Apnea and/or Cigarette Smoking on Endothelial Function

Start date: June 2008
Phase: N/A
Study type: Observational

The hypothesis of this study is that either obstructive sleep apnea (OSA) or cigarette smoking (CS) exposure would produce oxidative stress and inflammation leading to endothelial injury, and the combined exposure would be additive or synergistic.

NCT ID: NCT00956423 Completed - Clinical trials for Obstructive Sleep Apnea

Comparison of Physical Activity Regimens as Treatments for Obstructive Sleep Apnea

Start date: August 2009
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to compare the efficacy of two different physical activity regimens as complementary or alternative treatment options for the treatment of obstructive sleep apnea. A secondary purpose of the study is to examine the effects of these activity regimens on various health consequences of obstructive sleep apnea, including blood pressure, systemic inflammation, and daytime functioning.

NCT ID: NCT00952211 Terminated - Stroke Clinical Trials

Burden of Obstructive Sleep Apnea in Stroke (BOSAST)

BOSAST
Start date: August 2009
Phase: Phase 4
Study type: Interventional

There are two purposes of this study. The first purpose is to define the frequency of obstructive sleep apnea in stroke survivors as well as its association with fatigue and quality of life. The second purpose is to determine if continuous positive airways pressure (CPAP) treatment can have a beneficial effect on these patients' fatigue and quality of life.

NCT ID: NCT00952172 Completed - Clinical trials for Sleep Apnea Syndrome

Stair Stepping Exercise Training in Patients With Obstructive Sleep Apnea Syndrome

Start date: August 2006
Phase: Phase 2
Study type: Interventional

This 3-year prospective, randomized, control, longitudinal study is aimed to (1) examine the effect of stair stepping exercise training on cardiopulmonary fitness and sleep situation in patients with Obstructive Sleep Apnea Syndrome (OSAS), and (2) follow the longitudinal change after stair stepping exercise training in patients with OSAS. Patients meet the following criteria will be invited to participate in this study: being diagnosed with AHI (Apnea-hypopnea index)>15/hr and ODI (oxygen desaturation index)>10/hr by Polysomnography, aged 19 or older. Based on the power analysis, 70 patients with OSAS treated in the outpatient department of Chang Gung Medical Center will be recruited over a period of 26 months. Each patient will participate in this study for seventeen weeks. Patients will be randomly assigned to receive stair stepping exercise in addition to nursing education and standard care, or nursing education and standard care alone. Stair stepping exercise will be performed at home daily for eight weeks. Outcomes will be determined by changes in the scores of cardiopulmonary fitness index, VO2max, six-minute walking distance, daytime sleepiness measured by Epworth Sleepiness Scale, sleep time measured by Actigraphy, and AHI measured by Polysomnography; those taken four times: before treatment (baseline), five weeks, nine weeks, and seventeen weeks of the study. Data will be analyzed using descriptive statistics and Generalized Estimating Equation (GEE).

NCT ID: NCT00950495 Completed - Clinical trials for Obstructive Sleep Apnea

Oral Appliance Therapy in Obstructive Sleep Apnea

Start date: October 2003
Phase: N/A
Study type: Interventional

The aim of the study was to compare the effects of a mandibular advancement device (MAD) with those of nasal continuous positive airway pressure(nCPAP) and of an intra-oral placebo device in obstructive sleep apnea (OSA) patients. The hypothesis for this study was that both MAD therapy and nCPAP therapy have similar, better treatment effects than placebo therapy in OSA. The study was performed according to the CONSORT (consolidated standards of reporting trials) statement (Altman et al., 2001), employing a parallel-group, randomized, placebo-controlled trial design.

NCT ID: NCT00950287 Completed - Bradycardia Clinical Trials

Detection of Neonatal Bradycardia

INTEM
Start date: September 2009
Phase: N/A
Study type: Observational

Apnea-bradycardia is a frequent phenomenon in preterm infants which has been associated with short term complications and alterations in neurodevelopment. Duration and amplitude of the bradycardias depend on the time delay between the beginning of the bradycardia and the intervention of the nurse. The purpose of the study is to test a new method set for early detection of bradycardia in preterm infants.

NCT ID: NCT00947479 Recruiting - Clinical trials for Obstructive Sleep Apnea

Effect of Obstructive Sleep Apnea on Central Blood Pressure and Kidney and Endothelial Function

OSA-AKI
Start date: February 2009
Phase: N/A
Study type: Interventional

Obstructive sleep apnea (OSA) is a frequently underdiagnosed condition that has emerged as an increasing medical problem with important social and financial implications worldwide. OSA is a well established risk factor for systemic hypertension myocardial infarction or stroke and it has been documented that blood pressure rises in a very consistent fashion during apneic episodes. The incidence of the episodes of apnea during sleep causes repeated subclinical acute kidney injuries (AKI) contributing to the development of CKD. One of the mechanisms responsible for AKI might be endothelial injury followed by an increase of central aortic pressure.

NCT ID: NCT00942669 Completed - Clinical trials for Sleep Apnea Syndrome

Comparing the Sleep Strip OTC™ Accuracy in Screening for Sleep Apnea Syndrome Against the Reference Method, an In-lab Full Night Polysomnographic (PSG)

Start date: August 2009
Phase: Phase 1/Phase 2
Study type: Interventional

The primary purpose of this study is to demonstrate the equivalence of the new Sleep Strip OTC(TM) compared to the reference method of an in-lab, attended full-night polysomnographic (PSG) study.